Company

About UroMems

UroMems was founded in 2011 and focuses on designing, developing and commercializing active implantable medical devices.

The company is based at the heart of the French Alps, in the city of Grenoble, representing one of the most dynamic French area in the Medtechs industry.

UroMems is highly innovative and focuses on clearly identified clinical unmet needs, not only for their prevalence but also for their negative impact on patient’s quality of life.

Significative investments have been made in the development of the UroMems’ first product through 2 financing rounds, for a total amount of € 28 million. This includes the participation of Wellington Partners, Munich, Germany, Bpifrance via FABS Fund, Cita Investissement, Supernova Invest, b-to-v Partners AG, Hil-Invent, Financière Arbevel and the founders.

Our mission

UroMems’s mission is to offer implantable solutions that are:

Easy to use for the patients
Easy to operate for healthcare professionals
More effective, more reliable and less invasive than current surgical techniques

In a particularly demanding economic and regulatory context, the company’s ambition is to improve current surgical treatments for helping as many patients as possible, particularly by reducing associated side effects.

In order to fullfil this ambition, UroMems evolves in a leading-edge technology environment and has established partnerships with internationally renowned experts, research laboratories and industrial partners.

Led by the founders’ vision, UroMems follows the strictest ethics.